文献速递肝病

细胞外囊泡微小RNA组谱分析揭示代谢功能障碍相关脂肪性肝病患者微小RNA参与脂质代谢异常、慢性炎症和肝损伤

Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease.
PubMed 文献 · Aliment Pharmacol Ther · 2025-04-10

本研究对228例经活检证实的代谢功能障碍相关脂肪性肝病(MASLD)患者进行细胞外囊泡(EV)微小RNA(miRNA)组谱分析,并在54例亚组中开展体内代谢研究。结果发现7种miRNA与脂肪性肝炎诊断及显著纤维化(F≥2)相关,标志「高危MASH」;其中miR-122-5p和miR-375-3p与游离脂肪酸及脂肪组织胰岛素抵抗(AT-IR)直接相关,let-7d-5p和let-7f-5p与脂解、游离脂肪酸及促炎细胞因子呈负相关,并随AT-IR严重程度逐渐降低。结论提示这些miRNA在「高危MASH」患者的脂质代谢紊乱和炎症通路中相互交织,为后续研究其潜在治疗价值奠定基础。

要点

  • 7种EV miRNA(miR-27b-3p、miR-30a-5p、miR-122-5p、miR-375-3p、miR-103a-3p、let-7d-5p、let-7f-5p)与脂肪性肝炎诊断及显著纤维化(F≥2)相关,标志「高危MASH」。
  • miR-122-5p和miR-375-3p水平与循环游离脂肪酸及脂肪组织胰岛素抵抗直接相关。
  • let-7d-5p和let-7f-5p与脂解、游离脂肪酸及循环和肝脏促炎细胞因子表达呈负相关,并随AT-IR严重程度逐渐降低。

核心结论

  • 结果提示miR-122-5p、miR-375-3p与let-7家族在「高危MASH」患者的脂质代谢紊乱和炎症通路调节中相互交织,为后续研究其潜在治疗价值奠定基础。

研究设计与样本

  • 在228例经活检证实的MASLD患者中,采用NGS(NextSeq550,Illumina Inc)检测EV miRNA表达。
  • 在54例患者亚组中,通过示踪剂输注([6,6-2H2]葡萄糖和[2H5]甘油)进行体内代谢研究,评估葡萄糖和脂质通量及脂肪组织胰岛素抵抗。

主要发现

  • 7种miRNA(miR-27b-3p、miR-30a-5p、miR-122-5p、miR-375-3p、miR-103a-3p、let-7d-5p和let-7f-5p)根据脂肪性肝炎诊断及显著纤维化(F≥2)的存在呈现差异表达,从而标志「高危MASH」受试者。
  • 在代谢研究中,上述miRNA与脂质代谢的关联最强:miR-122-5p和miR-375-3p水平与循环游离脂肪酸(FFAs)及脂肪组织胰岛素抵抗(AT-IR)直接相关。
  • let-7d-5p和let-7f-5p与脂解、FFAs呈负相关,并随AT-IR严重程度逐渐降低。
  • let-7d-5p和let-7f-5p与循环和肝脏促炎细胞因子表达呈负相关,而促炎细胞因子随AT-IR程度增加而升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: MicroRNAs (miRNAs) are short non-coding oligonucleotides involved in the post-transcriptional regulation of gene expression. We investigated the association between the miRNome profile of circulating extracellular vesicles (EVs) and metabolic derangements, circulating and hepatic pro-inflammatory cytokines, and liver damage across the histological spectrum of metabolic dysfunction-associated steatotic liver disease (MASLD). METHODS: EV miRNAs expression was determined by NGS (NextSeq550, Illumina Inc) in 228 biopsy-proven MASLD patients. In vivo metabolic studies were performed in a subgroup of 54 patients by tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) to assess glucose and lipid fluxes and insulin resistance (IR) in the adipose tissue. RESULTS: Seven miRNAs (miR-27b-3p, miR-30a-5p, miR-122-5p, miR-375-3p, miR-103a-3p, let-7d-5p, and let-7f-5p) were differentially expressed according to the diagnosis of steatohepatitis and the presence of significant fibrosis (F ≥ 2), thus marking subjects with 'at-risk MASH'. In the metabolic studies, the above-reported miRNAs had the strongest associations with lipid metabolism: miR-122-5p and miR-375-3p levels directly correlated with circulating free fatty acids (FFAs) and adipose tissue (AT)-IR, while let-7d-5p and let-7f-5p inversely correlated with lipolysis, FFAs, and progressively decreased according to AT-IR severity. In addition, let-7d-5p and let-7f-5p inversely correlated with the circulating and hepatic expression of pro-inflammatory cytokines, which increased by increasing degrees of AT-IR. CONCLUSIONS: Our results suggest an intertwined connection between miR-122-5p, miR-375-3p, and the let-7 family in modulating lipid derangements and inflammatory pathways in patients with 'at-risk MASH', paving the basis for further studies aiming at investigating their potential therapeutic value.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Caviglia GP, Casalone E, Rosso C, et al. Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease. Aliment Pharmacol Ther. 2025. PMID: 40208030. doi:10.1111/apt.70150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。